Correlation Between Takeda Pharmaceutical and Neurocrine Biosciences

Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Takeda Pharmaceutical Co and Neurocrine Biosciences, you can compare the effects of market volatilities on Takeda Pharmaceutical and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Neurocrine Biosciences.

Diversification Opportunities for Takeda Pharmaceutical and Neurocrine Biosciences

-0.61

Correlation Coefficient

Takeda Pharmaceutical  Neurocrine Biosciences

Excellent diversification

The 3 months correlation between Takeda and Neurocrine is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Neurocrine Biosciences go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and Neurocrine Biosciences

Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to generate 0.42 times more return on investment than Neurocrine Biosciences. However, Takeda Pharmaceutical Co is 2.36 times less risky than Neurocrine Biosciences. It trades about 0.08 of its potential returns per unit of risk. Neurocrine Biosciences is currently generating about -0.03 per unit of risk. If you would invest  1,362  in Takeda Pharmaceutical Co on November 28, 2024 and sell it today you would earn a total of  74.00  from holding Takeda Pharmaceutical Co or generate 5.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Takeda Pharmaceutical Co  vs.  Neurocrine Biosciences

Takeda Pharmaceutical

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Takeda Pharmaceutical Co are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Neurocrine Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Neurocrine Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong forward indicators, Neurocrine Biosciences is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Takeda Pharmaceutical and Neurocrine Biosciences

The main advantage of trading using opposite Takeda Pharmaceutical and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.

The idea behind Takeda Pharmaceutical Co and Neurocrine Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.